S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
China's economy grows 8.1% in 2021, slows in second half
Group: Tax rich to fund vaccines for poor hit by pandemic
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
China's economy grows 8.1% in 2021, slows in second half
Group: Tax rich to fund vaccines for poor hit by pandemic
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
China's economy grows 8.1% in 2021, slows in second half
Group: Tax rich to fund vaccines for poor hit by pandemic
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
China's economy grows 8.1% in 2021, slows in second half
Group: Tax rich to fund vaccines for poor hit by pandemic
OTCMKTS:CLABF

Core One Labs Stock Forecast, Price & News

$1.44
+0.35 (+32.54%)
(As of 01/14/2022 03:55 PM ET)
Add
Compare
Today's Range
$1.14
▼
$1.44
50-Day Range
$0.46
▼
$1.73
52-Week Range
$0.36
▼
$4.25
Volume
103,000 shs
Average Volume
80,510 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive CLABF News and Ratings via Email

Sign-up to receive the latest news and ratings for Core One Labs and its competitors with MarketBeat's FREE daily newsletter.


Core One Labs logo

About Core One Labs

Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. Its focus is to bring psychedelic medicines to market through novel delivery systems and psychotherapy. The firm offers isogenics, cultivation, extraction and distillation, consulting, cannastrips, and quality and control. The company was founded on September 14, 2010 and is headquartered in Vancouver, Canada.

Headlines

Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022
January 15, 2022 |  finance.yahoo.com
Core One Labs Now Also Working to Biosynthesize DMT and Receives License
January 8, 2022 |  finance.yahoo.com
Short Interest in Core One Labs Inc. (OTCMKTS:CLABF) Expands By 19.8%
January 8, 2022 |  americanbankingnews.com
Core One Labs Applauds Health Canada's Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments
January 6, 2022 |  benzinga.com
Core One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments
January 5, 2022 |  finance.yahoo.com
Psychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition
December 27, 2021 |  msn.com
Core One Labs Acquires New Path Laboratories
December 23, 2021 |  finance.yahoo.com
Core One's Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
July 30, 2021 |  benzinga.com
Core One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements
July 16, 2021 |  finance.yahoo.com
REPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
June 21, 2021 |  finance.yahoo.com
New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
June 19, 2021 |  finance.yahoo.com
Core One Labs Retains Canada's Highest-Ranked IP Law Firm to Assist With Patent Filings
June 18, 2021 |  benzinga.com
Core One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
June 18, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CLABF
Previous Symbol
CUSIP
N/A
CIK
1640152
Web
core1labs.com
Phone
(866) 347-5058
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Core One Labs (OTCMKTS:CLABF) Frequently Asked Questions

Are investors shorting Core One Labs?

Core One Labs saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 24,800 shares, a decline of 22.7% from the December 15th total of 32,100 shares. Based on an average daily volume of 133,200 shares, the days-to-cover ratio is currently 0.2 days.
View Core One Labs' Short Interest.

Who are Core One Labs' key executives?

Core One Labs' management team includes the following people:
  • Joel Shacker, Chief Executive Officer & Director
  • Geoffrey Balderson, Chief Financial Officer & Secretary
  • John David Sanderson, Director & Chief Science Officer
  • Santiago Ferro, Chief Medical Officer
  • Phil Gurat, Head-Investor Relations

What is Core One Labs' stock symbol?

Core One Labs trades on the OTCMKTS under the ticker symbol "CLABF."

How do I buy shares of Core One Labs?

Shares of CLABF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core One Labs' stock price today?

One share of CLABF stock can currently be purchased for approximately $1.44.

What is Core One Labs' official website?

The official website for Core One Labs is core1labs.com.

Where are Core One Labs' headquarters?

Core One Labs is headquartered at 595 Burrard Street, Vancouver, BC V7X.

How can I contact Core One Labs?

Core One Labs' mailing address is 595 Burrard Street, Vancouver, BC V7X. The company can be reached via phone at (866) 347-5058.


This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.